Cargando…

Overlap between age-at-onset and disease-progression determinants in Huntington disease

OBJECTIVE: A fundamental but still unresolved issue regarding Huntington disease (HD) pathogenesis is whether the factors that determine age at onset are the same as those that govern disease progression. Because elucidation of this issue is crucial for the development as well as optimal timing of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aziz, N. Ahmad, van der Burg, Jorien M.M., Tabrizi, Sarah J., Landwehrmeyer, G. Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996832/ https://www.ncbi.nlm.nih.gov/pubmed/29743208 http://dx.doi.org/10.1212/WNL.0000000000005690

Ejemplares similares

Effect of Body Weight on Age at Onset in Huntington Disease: A Mendelian Randomization Study
por: van der Burg, Jorien M.M., et al.
Publicado: (2021)

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011)

The gene coding for PGC-1α modifies age at onset in Huntington's Disease
por: Weydt, Patrick, et al.
Publicado: (2009)

Progressive alterations in white matter microstructure across the timecourse of Huntington's disease
por: Estevez‐Fraga, Carlos, et al.
Publicado: (2023)

Disease Onset in Huntington's Disease: When Is the Conversion?
por: Oosterloo, Mayke, et al.
Publicado: (2021)

Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset
por: Gardiner, Sarah L., et al.
Publicado: (2018)

A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort
por: Weydt, Patrick, et al.
Publicado: (2014)

Age-at-onset in Huntington disease
por: Orth, Michael, et al.
Publicado: (2011)

Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
por: Lobanov, Sergey V., et al.
Publicado: (2022)

Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington’s Disease
por: Mansoor, Nina M., et al.
Publicado: (2021)

NMDA receptor gene variations as modifiers in Huntington disease: a replication study
por: Saft, Carsten, et al.
Publicado: (2011)

Commentary: Acanthocytes identified in Huntington's disease
por: Peikert, Kevin, et al.
Publicado: (2022)

Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington’s disease
por: Müller, Hans-Peter, et al.
Publicado: (2012)

Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease
por: Aziz, N. Ahmad, et al.
Publicado: (2009)

Influence of Age of Onset on Huntington’s Disease Phenotype
por: Kwa, Lauren, et al.
Publicado: (2020)

Intact sensory-motor network structure and function in far from onset premanifest Huntington’s disease
por: Gorges, Martin, et al.
Publicado: (2017)

Longitudinal expression changes are weak correlates of disease progression in Huntington’s disease
por: Mitchell, Christopher T, et al.
Publicado: (2020)

Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories
por: Ross, Christopher A., et al.
Publicado: (2019)

Current Pharmacological Management in Juvenile Huntington’s Disease
por: Robertson, Lisa, et al.
Publicado: (2012)

Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
por: Zhu, Yahui, et al.
Publicado: (2023)

Prodromal Huntington Disease as a Model for Functional Compensation of Early Neurodegeneration
por: Malejko, Kathrin, et al.
Publicado: (2014)

Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration
por: Estevez-Fraga, Carlos, et al.
Publicado: (2023)

Behavioral Deficits in Juvenile Onset Huntington’s Disease
por: Langbehn, Kathleen E., et al.
Publicado: (2020)

Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach()
por: Müller, Hans-Peter, et al.
Publicado: (2013)

Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington’S Disease Model
por: Landles, Christian, et al.
Publicado: (2020)

The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington’s Disease Patients
por: Anil, Megha, et al.
Publicado: (2020)

Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington’s disease
por: McColgan, Peter, et al.
Publicado: (2015)

Plasma neurofilament light in Huntington’s disease: A marker for disease onset, but not symptom progression
por: Parkin, Georgia M., et al.
Publicado: (2021)

Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease
por: Müller, Hans-Peter, et al.
Publicado: (2014)

PGC-1alpha as modifier of onset age in Huntington disease
por: Taherzadeh-Fard, Elahe, et al.
Publicado: (2009)

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
por: Klöppel, Stefan, et al.
Publicado: (2015)

Utilisation of Healthcare and Associated Services in Huntington’s disease: a data mining study
por: Busse, Monica, et al.
Publicado: (2011)

An International Validation of a Clinical Tool to Assess Carers’ Quality of Life in Huntington’s Disease
por: Aubeeluck, Aimee, et al.
Publicado: (2019)

Establishing normative data for the evaluation of cognitive performance in Huntington’s disease considering the impact of gender, age, language, and education
por: Mühlbäck, Alžbeta, et al.
Publicado: (2023)

CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset
Publicado: (2019)

Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study()
por: Hobbs, Nicola Z., et al.
Publicado: (2012)

Diffusion imaging in Huntington’s disease: comprehensive review
por: Estevez-Fraga, Carlos, et al.
Publicado: (2021)

The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington’s Disease
por: Schultz, Jordan L., et al.
Publicado: (2020)

Irritability in pre-clinical Huntington's disease
por: Klöppel, Stefan, et al.
Publicado: (2010)

Targets for future clinical trials in Huntington's disease: What's in the pipeline?
por: Wild, Edward J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_shp68o1vne0hkerg58h7k0v8c4